<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Pharmacol Toxicol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Pharmacol Toxicol</journal-id>
      <journal-title-group>
        <journal-title>BMC Pharmacology &amp; Toxicology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2050-6511</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25269374</article-id>
      <article-id pub-id-type="pmc">4185191</article-id>
      <article-id pub-id-type="publisher-id">2050-6511-15-57</article-id>
      <article-id pub-id-type="doi">10.1186/2050-6511-15-57</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pharmacokinetics and safety issues of an accidental overdose of 2,000,000&#xA0;IU of vitamin D<sub>3</sub> in two nursing home patients: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>van den Ouweland</surname>
            <given-names>Jody</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>j.v.d.ouweland@cwz.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Fleuren</surname>
            <given-names>Hanneke</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>fleuren@cwz.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Drabbe</surname>
            <given-names>Miranda</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>m_drabbe@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Vollaard</surname>
            <given-names>Hans</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>hvollaard@hotmail.nl</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Clinical Chemistry, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ Nijmegen, The Netherlands</aff>
      <aff id="I2"><label>2</label>Department of Clinical Pharmacy, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands</aff>
      <aff id="I3"><label>3</label>Nursing Home Waelwick, Ewijk Beuningen, The Netherlands</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <volume>15</volume>
      <fpage>57</fpage>
      <lpage>57</lpage>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>4</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014 van den Ouweland et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>van den Ouweland et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/2050-6511/15/57"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Administration of intermittent high doses of vitamin D<sub>3</sub> is increasingly used as a strategy for rapid normalization of low 25-hydroxyvitamin D (25(OH)D) blood concentrations in patients with vitamin D deficiency. Here, we describe the pharmacokinetics of an accidental single oral overdose of 2,000,000&#xA0;IU of vitamin D<sub>3</sub> in two elderly nursing home patients and discuss safety issues.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Two patients, a Caucasian 90-year old man and a 95-year old woman, were monitored from 1&#xA0;h up to 3&#xA0;months after intake for clinical as well as biochemical signs of vitamin D intoxication. Blood vitamin D<sub>3</sub> concentrations showed a prompt increase with the highest peak area already hours after the dose, followed by a rapid decrease to undetectable levels after day 14. Peak blood 25(OH)D<sub>3</sub> concentrations were observed 8&#xA0;days after intake (527 and 422&#xA0;nmol/L, respectively (ref: 50&#x2013;200&#xA0;nmol/L)). Remarkably, plasma calcium levels increased only slightly up to 2.68 and 2.73&#xA0;mmol/L, respectively (ref: 2.20&#x2013;2.65&#xA0;mmol/L) between 1 and 14&#xA0;days after intake, whereas phosphate and creatinine levels remained within the reference range. No adverse clinical symptoms were noted.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>A single massive oral dose of 2,000,000&#xA0;IU of vitamin D<sub>3</sub> does not cause clinically apparent toxicity requiring hospitalization, with only slightly elevated plasma calcium levels in the first 2&#xA0;weeks. Toxicity in the long term cannot be excluded as annual doses of 500,000&#xA0;IU of vitamin D<sub>3</sub> for several years have shown an increase in the risk of fractures. This means that plasma calcium levels may not be a sensitive measure of vitamin D toxicity in the long term in the case of a single high overdose. To prevent a similar error in the future, the use of multiple-dose bottles need to be replaced by smaller single-unit dose formulations.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Vitamin D</kwd>
        <kwd>Intoxication</kwd>
        <kwd>Single high dose</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Vitamin D deficiency is a highly prevalent condition, present in approximately 30&#x2013;50% of the general population [<xref ref-type="bibr" rid="B1">1</xref>], and may be as high as 100% in institutionalized elderly patients [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. Vitamin D supplementation is increasingly advised, but compliance with daily dosing regimens is low [<xref ref-type="bibr" rid="B4">4</xref>]. Because serum 25-hydroxyvitamin D<sub>3</sub> (25(OH)D<sub>3</sub>), the functional indicator of vitamin D status, has a long half-life of about 2&#xA0;months [<xref ref-type="bibr" rid="B5">5</xref>], there is great interest in intermittent dosing for patient convenience and long-term adherence. Administration of 100,000&#xA0;IU of cholecalciferol (vitamin D<sub>3</sub>) every 4&#xA0;months for 5&#xA0;years showed a 22% reduction in the risk of osteoporotic fractures [<xref ref-type="bibr" rid="B6">6</xref>], similar to studies using a daily dose of 800&#xA0;IU [<xref ref-type="bibr" rid="B7">7</xref>]. On the contrary, rapid increases in serum 25(OH)D from intermittent high doses of 500,000&#xA0;IU of vitamin D<sub>3</sub> once a year for 3&#x2013;5 years in older women, have been shown to increase the risk of falls and fractures by 26% compared with the use of a placebo [<xref ref-type="bibr" rid="B8">8</xref>]. In clinical studies using high-dose regimens of up to 600,000&#xA0;IU of vitamin D<sub>3</sub>, there has been surprisingly little concern for vitamin D toxicity. Plasma calcium and urinary calcium excretion both are recognized markers of vitamin D toxicity [<xref ref-type="bibr" rid="B5">5</xref>]. In the few clinical studies that have analyzed plasma calcium levels and/or urinary calcium excretion within a month after dosing, calcium levels were found to be unchanged or only slightly elevated within the reference range following a loading dose of 300,000&#xA0;IU [<xref ref-type="bibr" rid="B9">9</xref>], 500,000&#xA0;IU [<xref ref-type="bibr" rid="B10">10</xref>], 540,000&#xA0;IU [<xref ref-type="bibr" rid="B11">11</xref>], or 600,000&#xA0;IU [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p>
      <p>Here, we describe the pharmacokinetics of an accidental overdosing by 2,000,000&#xA0;IU vitamin D<sub>3</sub> in two elderly nursing home patients and discuss safety issues from single massive oral doses of vitamin D<sub>3</sub>.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>In Waelwick, a nursing home near Nijmegen, all residents receive osteoporosis prophylaxis with oral vitamin D<sub>3</sub> doses of 100,000&#xA0;IU three times a year as a lyophilized solution (2&#xA0;mL vitamin D<sub>3</sub> aquosum FNA, 50,000&#xA0;IU/mL). Two nursing home patients each received an accidental single overdose of 2,000,000&#xA0;IU vitamin D from a whole bottle of a concentrated vitamin D<sub>3</sub> solution (40&#xA0;mL vitamin D<sub>3</sub> aquosum FNA 50,000&#xA0;IU/mL). The pharmacy department was surprised by the order for 25 new bottles immediately after the dose, as the two 40-mL bottles would have lasted for half of a year of treatment for the patients at the ward. It then became clear that an overdose had been given. For safety reasons, we immediately started biochemical and clinical monitoring of both patients. Plasma calcium, phosphate, creatinine, and 25(OH)D levels were measured from 1&#xA0;h after dosing up to 106&#xA0;days (case 1) and 71&#xA0;days (case 2) (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>, Table&#xA0;<xref ref-type="table" rid="T1">1</xref>). Vitamin D<sub>3</sub> was measured at time points 1&#xA0;h, 0.5, 1, 2, 8, and 14&#xA0;days after dosing (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). Because of the nature of this study, baseline concentrations (prior to dosing) were lacking. Unfortunately, we lacked the opportunity for measuring 1,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D (because of limited availability of plasma material), parathyroid hormone (PTH) and bone turnover markers (lack of the appropriate blood containers or pre-analytical conditions), and urinary calcium excretion (lack of urine collection).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Time course of plasma calcidiol and calcium concentrations, as well as semi-quantitative measurements of plasma vitamin D</bold><sub><bold>3 </bold></sub><bold>(cholecalciferol), after a single oral dose of 2,000,000&#xA0;IU of vitamin D to two nursing home residents.</bold> The asterisk indicates the individual calcium measurements that show a biologically significant difference from baseline concentrations. Note the time-scale differences between the vitamin D<sub>3</sub> (cholecalciferol) and the upper plots.</p>
        </caption>
        <graphic xlink:href="2050-6511-15-57-1"/>
      </fig>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Biochemical values from single high-dose vitamin D3 administration in two cases</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">&#xA0;</th>
              <th align="left">&#xA0;</th>
              <th align="left">
                <bold>Reference range</bold>
              </th>
              <th align="left">
                <bold>1&#xA0;h</bold>
              </th>
              <th align="left">
                <bold>5.5&#xA0;h</bold>
              </th>
              <th align="left">
                <bold>1d</bold>
              </th>
              <th align="left">
                <bold>2d</bold>
              </th>
              <th align="left">
                <bold>3d</bold>
              </th>
              <th align="left">
                <bold>4d</bold>
              </th>
              <th align="left">
                <bold>8d</bold>
              </th>
              <th align="left">
                <bold>11d</bold>
              </th>
              <th align="left">
                <bold>14d</bold>
              </th>
              <th align="left">
                <bold>22d</bold>
              </th>
              <th align="left">
                <bold>29d</bold>
              </th>
              <th align="left">
                <bold>36d</bold>
              </th>
              <th align="left">
                <bold>43d</bold>
              </th>
              <th align="left">
                <bold>60d</bold>
              </th>
              <th align="left">
                <bold>71d</bold>
              </th>
              <th align="left">
                <bold>106d</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td rowspan="4" align="left" valign="bottom">Case 1<hr/></td>
              <td align="left" valign="bottom">Calcidiol (nmol/L)<hr/></td>
              <td align="left" valign="bottom">50-200<hr/></td>
              <td align="left" valign="bottom">59<hr/></td>
              <td align="left" valign="bottom">
                <bold>224</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>395</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>448</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>527</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>522</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>403</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>323</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>318</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>283</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>203</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">131<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Calcium (mmol/L)<hr/></td>
              <td align="left" valign="bottom">2.20-2.65<hr/></td>
              <td align="left" valign="bottom">2.52<hr/></td>
              <td align="left" valign="bottom">2.51<hr/></td>
              <td align="left" valign="bottom">2.57<hr/></td>
              <td align="left" valign="bottom">2.64<hr/></td>
              <td align="left" valign="bottom">
                <bold>2.67</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">2.64<hr/></td>
              <td align="left" valign="bottom">
                <bold>2.68</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">2.63<hr/></td>
              <td align="left" valign="bottom">2.57<hr/></td>
              <td align="left" valign="bottom">2.45<hr/></td>
              <td align="left" valign="bottom">2.5<hr/></td>
              <td align="left" valign="bottom">2.5<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">2.43<hr/></td>
              <td align="left" valign="bottom">2.43<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Phosphate (mmol/L)<hr/></td>
              <td align="left" valign="bottom">0.80-1.40<hr/></td>
              <td align="left" valign="bottom">1.08<hr/></td>
              <td align="left" valign="bottom">1.09<hr/></td>
              <td align="left" valign="bottom">1.05<hr/></td>
              <td align="left" valign="bottom">1.30<hr/></td>
              <td align="left" valign="bottom">1.13<hr/></td>
              <td align="left" valign="bottom">1.14<hr/></td>
              <td align="left" valign="bottom">1.37<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">1.32<hr/></td>
              <td align="left" valign="bottom">1.01<hr/></td>
              <td align="left" valign="bottom">1.00<hr/></td>
              <td align="left" valign="bottom">0.98<hr/></td>
              <td align="left" valign="bottom">0.97<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">0.96<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Creatinine (&#x3BC;mol/L)<hr/></td>
              <td align="left" valign="bottom">60-110<hr/></td>
              <td align="left" valign="bottom">64<hr/></td>
              <td align="left" valign="bottom">65<hr/></td>
              <td align="left" valign="bottom">66<hr/></td>
              <td align="left" valign="bottom">68<hr/></td>
              <td align="left" valign="bottom">69<hr/></td>
              <td align="left" valign="bottom">73<hr/></td>
              <td align="left" valign="bottom">69<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">77<hr/></td>
              <td align="left" valign="bottom">75<hr/></td>
              <td align="left" valign="bottom">71<hr/></td>
              <td align="left" valign="bottom">69<hr/></td>
              <td align="left" valign="bottom">63<hr/></td>
              <td align="left" valign="bottom">66<hr/></td>
              <td align="left" valign="bottom">75<hr/></td>
              <td align="left" valign="bottom">65<hr/></td>
            </tr>
            <tr>
              <td rowspan="4" align="left">Case 2</td>
              <td align="left" valign="bottom">Calcidiol (nmol/L)<hr/></td>
              <td align="left" valign="bottom">50-200<hr/></td>
              <td align="left" valign="bottom">77<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>326</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>354</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>422</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>405</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>363</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>322</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>324</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>255</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>233</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Calcium (mmol/L)<hr/></td>
              <td align="left" valign="bottom">2.20-2.65<hr/></td>
              <td align="left" valign="bottom">2.46<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>2.69</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>2.73</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>2.68</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>2.69</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>2.66</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">
                <bold>2.70</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">2.57<hr/></td>
              <td align="left" valign="bottom">2.59<hr/></td>
              <td align="left" valign="bottom">2.50<hr/></td>
              <td align="left" valign="bottom">2.49<hr/></td>
              <td align="left" valign="bottom">2.59<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">2.57<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Phosphate (mmol/L)<hr/></td>
              <td align="left" valign="bottom">0.80-1.40<hr/></td>
              <td align="left" valign="bottom">0.91<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">1.20<hr/></td>
              <td align="left" valign="bottom">1.06<hr/></td>
              <td align="left" valign="bottom">1.12<hr/></td>
              <td align="left" valign="bottom">1.05<hr/></td>
              <td align="left" valign="bottom">1.13<hr/></td>
              <td align="left" valign="bottom">1.02<hr/></td>
              <td align="left" valign="bottom">1.07<hr/></td>
              <td align="left" valign="bottom">0.82<hr/></td>
              <td align="left" valign="bottom">0.82<hr/></td>
              <td align="left" valign="bottom">0.89<hr/></td>
              <td align="left" valign="bottom">0.87<hr/></td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
              <td align="left" valign="bottom">
                <bold>0.79</bold>
                <hr/>
              </td>
              <td align="left" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left">Creatinine (&#x3BC;mol/L)</td>
              <td align="left">50-90</td>
              <td align="left">
                <bold>45</bold>
              </td>
              <td align="left">&#xA0;</td>
              <td align="left">51</td>
              <td align="left">
                <bold>44</bold>
              </td>
              <td align="left">55</td>
              <td align="left">54</td>
              <td align="left">52</td>
              <td align="left">52</td>
              <td align="left">
                <bold>49</bold>
              </td>
              <td align="left">52</td>
              <td align="left">
                <bold>41</bold>
              </td>
              <td align="left">50</td>
              <td align="left">54</td>
              <td align="left">&#xA0;</td>
              <td align="left">
                <bold>45</bold>
              </td>
              <td align="left">&#xA0;</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Values outside the reference range are indicated in bold. h, hours; d, days. Conversion factors: calcidiol (mg/dL&#x2009;=&#x2009;0.4&#x2009;&#xD7;&#x2009;mmol/L), calcium (mg/dL&#x2009;=&#x2009;4&#x2009;&#xD7;&#x2009;mmol/L), phosphate (mg/dL&#x2009;=&#x2009;3.1&#x2009;&#xD7;&#x2009;mmol/L), creatinine (mg/dL&#x2009;=&#x2009;0.01&#x2009;&#xD7;&#x2009;&#x3BC;mol/L).</p>
        </table-wrap-foot>
      </table-wrap>
      <p>Measurements of plasma 25(OH)D concentrations, as well as semi-quantitative measurement of vitamin D<sub>3</sub> (monitoring peak area), were performed using liquid chromatography-tandem mass spectrometry as previously described [<xref ref-type="bibr" rid="B14">14</xref>]. Plasma calcium, phosphate, and creatinine levels were measured on a routine clinical chemistry analyzer (Modular; Roche Diagnostics, Mannheim, Germany). Changes of biological significance were calculated from reference change (RCV, at a 95% confidence interval) according to the formula RCV = Z&#x2009;&#xD7;&#x2009;2<sup>1/2</sup><inline-formula><mml:math id="M1" name="2050-6511-15-57-i1" overflow="scroll"><mml:mi>(</mml:mi><mml:msubsup><mml:mi mathvariant="normal">CV</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">2</mml:mi></mml:msubsup><mml:mi>+</mml:mi><mml:msubsup><mml:mi mathvariant="normal">CV</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">2</mml:mi></mml:msubsup><mml:mi>)</mml:mi></mml:math></inline-formula><sup>1/2</sup>[<xref ref-type="bibr" rid="B15">15</xref>], where Z&#x2009;=&#x2009;1.96 (i.e., the Z-score for 95% confidence), CV<sub>a</sub> = analytical variation, and CV<sub>i</sub> = intra-individual variation. For calcium, CV<sub>a</sub> and CV<sub>i</sub> were 1.5% and 1.9%, respectively [<xref ref-type="bibr" rid="B16">16</xref>].</p>
      <p>Case 1 was a 90-year-old man of Caucasian origin, with normal kidney function (estimated glomerular filtration rate by Modification of Diet in Renal Disease (MDRD) equation &gt;60&#xA0;mL/min), and an absence of significant pathology. He did not report any clinical signs or symptoms of vitamin D toxicity. His plasma calcium was 2.52&#xA0;mmol/L 1&#xA0;h after dosing and showed a non-significant increase from day 1 to day 8, with a maximum of 2.68&#xA0;mmol/L at day 8. After 8&#xA0;days, plasma calcium levels fell to within the reference range (2.2&#x2013;2.65&#xA0;mmol/L) (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). At first measurement, 1&#xA0;h after gift, vitamin D3 was already detected. The vitamin D<sub>3</sub> peak area showed a prompt increase with the highest peak area already at the second measurement, 5.5&#xA0;h after dosing, followed by a rapid decrease to undetectable levels at day 14. Plasma 25(OH)D<sub>3</sub> concentrations also were already markedly increased 5.5&#xA0;h after dosing, but rose more slowly than vitamin D<sub>3</sub>, reaching a maximum of 527&#xA0;nmol/L at day 8. Over the following 3-month period, 25(OH)D<sub>3</sub> concentrations decreased by 50% over an approximately 50-day period. At the end of the 106-day follow-up period, the patient&#x2019;s 25(OH)D<sub>3</sub> concentration was 113&#xA0;nmol/L and fell within the laboratory reference range (50&#x2013;200&#xA0;nmol/L). Plasma phosphate and creatinine levels showed a modest increase within the reference range (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>).</p>
      <p>Case 2 relates to a 95-year-old woman of Caucasian origin, with normal kidney function (MDRD &gt;60&#xA0;mL/min) and an absence of significant pathology. She did not report any clinical signs or symptoms of vitamin D toxicity. Her plasma calcium was 2.46&#xA0;mmol/L 1&#xA0;h after dosing and showed a biologically significant increase from day 1 to day 11 with a maximum of 2.73&#xA0;mmol/L at the second day. After 11&#xA0;days, plasma calcium levels dropped to within the reference range of 2.2&#x2013;2.65&#xA0;mmol/L (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). Vitamin D<sub>3</sub> peak area was highest at the first measurement opportunity, being 1-day post-dose, followed by a rapid decrease to undetectable levels after day 14. Plasma 25(OH)D<sub>3</sub> concentrations also were already markedly increased 1&#xA0;day after dosing, but rose more slowly than vitamin D<sub>3</sub>, reaching a maximum of 422&#xA0;nmol/L at day 8. At the end of the 71-day follow-up period, the 25(OH)D<sub>3</sub> concentration was 233&#xA0;nmol/L, with an approximate 50% decrease from the highest level being still above the upper normal limit of 200&#xA0;nmol/L. Plasma phosphate and creatinine levels both showed a modest increase within the reference range (Table&#xA0;<xref ref-type="table" rid="T1">1</xref>).</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Pharmacokinetic studies in human volunteers given a single large oral dose of 100,000&#xA0;IU of vitamin D<sub>3</sub> indicate that serum vitamin D<sub>3</sub> and 25(OH)D<sub>3</sub> levels peak on days 1 and 7, respectively [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. The vitamin D<sub>3</sub> concentrations fell rapidly, being close to baseline by day 7, with a much slower fall of the 25(OH)D<sub>3</sub> concentrations. Plasma calcium levels did not rise at any time, and no subject experienced hypercalcemia at any of the measured time points [<xref ref-type="bibr" rid="B17">17</xref>]. The pharmacokinetic profiles of our two cases resembled those from the 100,000&#xA0;IU study and emphasize the importance of measuring 25(OH)D and calcium concentrations over the first 14&#xA0;days for identifying the maximum blood concentrations. The half-life of the plasma 25(OH)D levels of about 50&#xA0;days in case 1 is comparable to a half-life of about 2&#xA0;months as described previously [<xref ref-type="bibr" rid="B5">5</xref>]. The relatively normal 25(OH)D<sub>3</sub> concentrations in our nursing home residents (59&#xA0;nmol/L in case 1 and 77&#xA0;nmol/L in case 2) at the first measurement (1&#xA0;h post-dosing) can be explained as the result of previous osteoporosis prophylaxis treatments with 100,000&#xA0;IU of oral vitamin D<sub>3</sub>. However, we cannot exclude the possibility that the plasma 25(OH)D concentrations were already increased 1&#xA0;h after the high dose of vitamin D<sub>3</sub>, implicating that the baseline 25(OH)D values in both cases actually may have been lower.</p>
      <p>The toxicity of vitamin D in daily administration has been studied extensively. The present view is that hypercalcemia is the hazard criterion for vitamin D [<xref ref-type="bibr" rid="B19">19</xref>]. Thus, vitamin D toxicity is supposed to be inseparable from hypercalcemia. Hypercalcemia does not occur with daily doses up to 40,000&#xA0;IU of vitamin D<sub>3</sub> and serum levels of 25(OH)D<sub>3</sub> up to 500&#xA0;nmol/L, well above naturally occurring levels of 25(OH)D<sub>3</sub>[<xref ref-type="bibr" rid="B20">20</xref>]. Most patients with an overdose of vitamin D<sub>3</sub> are not seen by a physician until they are admitted to the emergency department with clinical signs of intoxication, such as life-threatening dehydration, after a prolonged period of oral intake of high-dose vitamin D, either from contaminated food components [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>] or supplements with errors in manufacturing and/or labeling [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p>
      <p>Much less is known about the toxicity of vitamin D<sub>3</sub> following a single high oral dose of vitamin D<sub>3</sub>. In studies using 300,000&#xA0;IU [<xref ref-type="bibr" rid="B9">9</xref>], 540,000&#xA0;IU [<xref ref-type="bibr" rid="B11">11</xref>], and 600,000&#xA0;IU [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>] of oral vitamin D<sub>3</sub>, no adverse effects were noted and plasma calcium levels or urinary calcium excretion did not change, or only slightly increased for a short period of time, with all cases remaining within the physiological range. In contrast to these reassuring data, Sanders et al. [<xref ref-type="bibr" rid="B8">8</xref>] found a significant increase in the risk of falls (+15%) and fractures (+26%) in a randomized controlled trial with an annual dose of 500,000&#xA0;IU vitamin D<sub>3</sub> for 3&#x2013;5 years in older women compared with placebo. Falls and fractures occurred especially within the first 3&#xA0;months following the annual dose of vitamin D<sub>3</sub>. In that study, plasma calcium levels and urinary calcium excretion were not measured; however, bearing in mind the former data, it is unlikely that hypercalcemia occurred in the study. These unexpected findings led Rossini et al. [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B25">25</xref>] to investigate dose-dependent short-term effects on bone turnover markers of a single bolus of vitamin D<sub>3</sub>. A single dose of 600,000&#xA0;IU of vitamin D<sub>3</sub> increased serum C-terminal telopeptide of type 1 collagen and cross-linked N-telopeptide of type 1 collagen significantly at day 1, attained a peak increment greater than 50% at day 3, and subsequently decreased almost back to baseline values at day 90, without statistically significant changes in plasma calcium [<xref ref-type="bibr" rid="B13">13</xref>]. Their results indicate that the use of oral megadoses greater than 100,000&#xA0;IU of vitamin D may be counterproductive and that the safety issues surrounding vitamin D dosing should not be limited to early markers of vitamin D toxicity as plasma hypercalcemia or increased urinary calcium excretion [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. A possible explanation is the fact that the level of 1,25 dihydroxy-vitamin D is regulated much stronger in the endocrine system than in the autocrine system of vitamin D [<xref ref-type="bibr" rid="B5">5</xref>]. If the plasma level of calcidiol (the substrate of the autocrine vitamin D system) increases sharply after a loading dose that deviates too much from the maximum physiological daily dose with sunlight (20,000&#xA0;IU), this might result in toxic intracellular calcitriol levels in the autocrine vitamin D system without toxic circulating calcitriol levels in the endocrine system of vitamin D and without hypercalcemia. If that is the case, we need other markers than hypercalcemia to prove vitamin D toxicity in the autocrine system, such as bone turnover markers [<xref ref-type="bibr" rid="B13">13</xref>]. In any case, more studies are needed to evaluate potential adverse effects of high-dose vitamin D treatment on bone metabolism in relation to fracture risk and risk of falls.</p>
      <p>The present study displays some limitations. We lacked the opportunity for studying other relevant parameters in the risk assessment for vitamin D<sub>3</sub>, such as measurement of urinary calcium excretion and plasma levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, PTH, and bone turnover markers. Because of the nature of this study, baseline concentrations (prior to dosing) of biochemical parameters such as plasma vitamin D<sub>3</sub>, 25(OH)D, and calcium were lacking.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>In our two patients, the massive single overdose of 2,000,000&#xA0;IU of vitamin D<sub>3</sub> did not result in immediate clinical and biochemical toxicity requiring hospitalization, with only slightly elevated plasma calcium levels in the first 2&#xA0;weeks. However, toxicity in the long term cannot be excluded as an annual dose of 500,000&#xA0;IU of vitamin D<sub>3</sub> for several years has shown an increased risk of fractures. This may implicate that markers other than plasma calcium measurement, such as bone turnover markers, are needed to assess the safety of high doses of vitamin D in the long term. Clearly, the safety of high-dose vitamin D supplementation warrants further study. To prevent a similar error in the future, the use of multiple-dose bottles were replaced by smaller single-unit dose formulations of 25.000&#xA0;IU/mL. In general, we believe that available formulations of vitamin D<sub>3</sub> should not exceed 100,000&#xA0;IU, as long as the safety of high doses of vitamin D in the long term has not been established.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent for publication of their clinical details was obtained from the relatives of both patients. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>25(OH)D: 25-hydroxyvitamin D; CV<sub>a</sub>: analytical variation; CV<sub>i</sub>: intra-individual variation; RCV: reference change value.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>MD was the treating physician of the patients reported. JvdO carried out the biochemical measurements, evaluated the test results and drafted the manuscript. HF and HV evaluated the test results and helped to draft the manuscript. All authors read and approved the final version of the manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/2050-6511/15/57/prepub">http://www.biomedcentral.com/2050-6511/15/57/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgments</title>
      <p>The authors declare that they have no acknowledgments and/or sources of funding.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Holick</surname>
            <given-names>MF</given-names>
          </name>
          <article-title>Vitamin D: evolutionary, physiological and health perspectives</article-title>
          <source>Curr Drug Targets</source>
          <year>2011</year>
          <volume>12</volume>
          <fpage>4</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.2174/138945011793591635</pub-id>
          <pub-id pub-id-type="pmid">20795941</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lips</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications</article-title>
          <source>Endocr Rev</source>
          <year>2001</year>
          <volume>22</volume>
          <fpage>477</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="doi">10.1210/edrv.22.4.0437</pub-id>
          <pub-id pub-id-type="pmid">11493580</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Pilz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dobnig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tomaschitz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kienreich</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Meinitzer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Friedl</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Piswanger-S&#xF6;lkner</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>M&#xE4;rz</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fahrleitner-Pammer</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2012</year>
          <volume>97</volume>
          <fpage>E653</fpage>
          <lpage>E657</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2011-3043</pub-id>
          <pub-id pub-id-type="pmid">22319037</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bischoff-Ferrari</surname>
            <given-names>HA</given-names>
          </name>
          <article-title>How to select the dose of vitamin D in the management of osteoporosis</article-title>
          <source>Osteoporosis Int</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>401</fpage>
          <lpage>407</lpage>
          <pub-id pub-id-type="doi">10.1007/s00198-006-0293-9</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="book">
          <name>
            <surname>Vieth</surname>
            <given-names>R</given-names>
          </name>
          <person-group person-group-type="editor">Vitamin D</person-group>
          <article-title>The Pharmacology of Vitamin D</article-title>
          <source>Chapter 57 in Feldman, Pike and Adams</source>
          <year>2011</year>
          <edition>3, volume II</edition>
          <publisher-name>London, UK: Academic</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Trivedi</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Dolf</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Khaw</surname>
            <given-names>KT</given-names>
          </name>
          <article-title>Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial</article-title>
          <source>BMJ</source>
          <year>2003</year>
          <volume>326</volume>
          <fpage>469</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="doi">10.1136/bmj.326.7387.469</pub-id>
          <pub-id pub-id-type="pmid">12609940</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dawson-Hughes</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Heaney</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Holick</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Lips</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Meunier</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Vieth</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Estimates of optimal vitamin D status</article-title>
          <source>Osteoporosis Int</source>
          <year>2005</year>
          <volume>16</volume>
          <fpage>713</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="doi">10.1007/s00198-005-1867-7</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sanders</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Williamson</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Simpson</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Kotowicz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Nicholson</surname>
            <given-names>GC</given-names>
          </name>
          <article-title>Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial</article-title>
          <source>JAMA</source>
          <year>2010</year>
          <volume>303</volume>
          <fpage>1815</fpage>
          <lpage>1822</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.2010.594</pub-id>
          <pub-id pub-id-type="pmid">20460620</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Romagnoli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mascia</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Cipriani</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fassino</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Mazzei</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>D&#x2019;Erasmo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Carnevale</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Scillitani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Minisola</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2008</year>
          <volume>93</volume>
          <fpage>3015</fpage>
          <lpage>3020</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2008-0350</pub-id>
          <pub-id pub-id-type="pmid">18492750</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bacon</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Gamble</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Horne</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Reid</surname>
            <given-names>IR</given-names>
          </name>
          <article-title>High-dose oral vitamin D3 supplementation in the elderly</article-title>
          <source>Osteoporos Int</source>
          <year>2009</year>
          <volume>20</volume>
          <fpage>1407</fpage>
          <lpage>1415</lpage>
          <pub-id pub-id-type="doi">10.1007/s00198-008-0814-9</pub-id>
          <pub-id pub-id-type="pmid">19101755</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Amrein</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sourij</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Holl</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pieber</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Smolle</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Stojakovic</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schnedl</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dobnig</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Short term effects of high dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double blind, placebo controlled pilot study</article-title>
          <source>Crit Care</source>
          <year>2011</year>
          <volume>15</volume>
          <fpage>R104</fpage>
          <pub-id pub-id-type="doi">10.1186/cc10120</pub-id>
          <pub-id pub-id-type="pmid">21443793</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cipriani</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Romagnoli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Scillatani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chiodini</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Clerico</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Carnevale</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Mascia</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Battista</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Viti</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pileri</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eller-Vainicher</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Minisola</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Effect of a single oral dose of 600,000 IU of cholecalciferol in serum calciotropic hormones in young subjects with vitamin D deficiency: A prospective intervention study</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2010</year>
          <volume>95</volume>
          <fpage>4771</fpage>
          <lpage>4777</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2010-0502</pub-id>
          <pub-id pub-id-type="pmid">20660032</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rossini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gatti</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Viapiana</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Fracassi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Idolazzi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zanoni</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Adami</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Short term effects on bone turnover markers of a single high dose of oral vitamin D3</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2012</year>
          <volume>97</volume>
          <fpage>E622</fpage>
          <lpage>E626</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2011-2448</pub-id>
          <pub-id pub-id-type="pmid">22298802</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>van den Ouweland</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Beijers</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Demacker</surname>
            <given-names>PN</given-names>
          </name>
          <name>
            <surname>van Daal</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay</article-title>
          <source>J Chromatogr B Analyt Technol Biomed Life Sci</source>
          <year>2010</year>
          <volume>878</volume>
          <fpage>1163</fpage>
          <lpage>1168</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jchromb.2010.03.035</pub-id>
          <pub-id pub-id-type="pmid">20381436</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="book">
          <name>
            <surname>Fraser</surname>
            <given-names>CG</given-names>
          </name>
          <source>Biological Variation: From Principles to Practice</source>
          <year>2001</year>
          <publisher-name>Washington: AACC press</publisher-name>
          <fpage>67</fpage>
          <lpage>70</lpage>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ric&#xF3;s</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Iglesias</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Garc&#xED;a-Lario</surname>
            <given-names>JV</given-names>
          </name>
          <name>
            <surname>Sim&#xF3;n</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cava</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hern&#xE1;ndez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Perich</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Minchinela</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Alvarez</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Dom&#xE9;nech</surname>
            <given-names>MV</given-names>
          </name>
          <name>
            <surname>Jim&#xE9;nez</surname>
            <given-names>CV</given-names>
          </name>
          <name>
            <surname>Biosca</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tena</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Within-subject biological variation in disease: collated data and clinical consequences</article-title>
          <source>Ann Clin Biochem</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>343</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="doi">10.1258/000456307780945633</pub-id>
          <pub-id pub-id-type="pmid">17594781</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ilahi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Armas</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Heaney</surname>
            <given-names>RP</given-names>
          </name>
          <article-title>Pharmacokinetics of a single, large dose of cholecalciferol</article-title>
          <source>Am J Clin Nutr</source>
          <year>2008</year>
          <volume>87</volume>
          <fpage>688</fpage>
          <lpage>691</lpage>
          <pub-id pub-id-type="pmid">18326608</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Heaney</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Armas</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Shary</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Bell</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Binkley</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hollis</surname>
            <given-names>BW</given-names>
          </name>
          <article-title>25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions</article-title>
          <source>Am J Clin Nutr</source>
          <year>2008</year>
          <volume>87</volume>
          <fpage>1738</fpage>
          <lpage>1742</lpage>
          <pub-id pub-id-type="pmid">18541563</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vieth</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Vitamin D toxicity, policy, and science</article-title>
          <source>J Bone Miner Res</source>
          <year>2007</year>
          <volume>22</volume>
          <issue>Suppl 2</issue>
          <fpage>V64</fpage>
          <lpage>V68</lpage>
          <pub-id pub-id-type="pmid">18290725</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vieth</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety</article-title>
          <source>Am J Clin Nutr</source>
          <year>1999</year>
          <volume>69</volume>
          <fpage>842</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="pmid">10232622</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vieth</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pinto</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Reen</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>MM</given-names>
          </name>
          <article-title>Vitamin D poisoning by table sugar</article-title>
          <source>Lancet</source>
          <year>2002</year>
          <volume>359</volume>
          <fpage>672</fpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(02)07814-5</pub-id>
          <pub-id pub-id-type="pmid">11879864</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Down</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Polak</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Regan</surname>
            <given-names>RJ</given-names>
          </name>
          <article-title>A family with massive acute vitamin D intoxication</article-title>
          <source>Postgrad Med J</source>
          <year>1979</year>
          <volume>55</volume>
          <fpage>897</fpage>
          <lpage>902</lpage>
          <pub-id pub-id-type="doi">10.1136/pgmj.55.650.897</pub-id>
          <pub-id pub-id-type="pmid">232912</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Araki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Holick</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Alfonso</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Charlap</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Romero</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Rizk</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Newman</surname>
            <given-names>LG</given-names>
          </name>
          <article-title>Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2011</year>
          <volume>96</volume>
          <fpage>3603</fpage>
          <lpage>3608</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2011-1443</pub-id>
          <pub-id pub-id-type="pmid">21917864</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lowe</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Cusano</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Binkley</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Blaner</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>Bilezikian</surname>
            <given-names>JP</given-names>
          </name>
          <article-title>Vitamin D toxicity due to a commonly available &#x201C;over the counter&#x201D; remedy from the Dominican Republic</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2011</year>
          <volume>96</volume>
          <fpage>291</fpage>
          <lpage>295</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2010-1999</pub-id>
          <pub-id pub-id-type="pmid">21123442</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rossini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Adami</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Viapiana</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Fracassi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Idolazzi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Povine</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Gatti</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers</article-title>
          <source>Calcif Tissue Int</source>
          <year>2012</year>
          <volume>91</volume>
          <fpage>365</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="doi">10.1007/s00223-012-9637-y</pub-id>
          <pub-id pub-id-type="pmid">23052222</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
